Financials

  • Market Capitalization 90.28 M
  • Employee 73
  • Founded 1982
  • CEO Michael F Brigham
  • Website www.immucell.com
  • Headquarter Delaware, United States
  • FIGI BBG000BLQ5Q2
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
143.57
Rapporto prezzo/fatturato
2.97

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3972
ATRA
Atara Biotherapeutics, Inc. - Common Stock
9.20 USD-0.54%-3.87%+12.61%-37.63%92.35 M USD
3973
PYPD
PolyPid Ltd. - Ordinary Shares
5.07 USD-0.98%-0.98%+14.97%+49.56%92.29 M USD
3987
ALDX
Aldeyra Therapeutics, Inc. - Common Stock
1.49 USD-3.25%-2.61%-8.02%-74.40%89.89 M USD
3994
RLYB
Rallybio Corporation - Common Stock
16.81 USD+0.30%+1.63%+5.66%+3132.69%89.27 M USD

Notizie